A Ph2 Study to Evaluate the Safety, Efficacy and Tolerability of HT-6184 and Semaglutide in Obese Participants With T2DM
Clinical trial NCT07172867 · WITHDRAWN
Trial details
- NCT number
- NCT07172867
- Sponsor
- Halia Therapeutics, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-06
- Primary completion
- 2026-01-23
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.